ABBOTT LABORATORIES — Director's Dealing 2019

Aug 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2019-08-01

Reporting Person: Moreland Mary K (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-01	Common shares without par value	A	8426	—	Acquired	56028	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-01	Option (right to buy)	$86.86	A	60912	Acquired	2029-07-31	Common shares (60912)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	10551	Indirect

Footnotes

F1: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of August 2, 2019.

F3: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,304 on August 1, 2020, 20,304 on August 1, 2021, and 20,304 on August 1, 2022.